ArticleJournal of the American Academy of Dermatology2020
Male balding is a major risk factor for severe COVID-19.
Article in Journal of the American Academy of Dermatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT04898166 (Association of Androgenetic Alopecia and Severity of Coronavirus Disease 2019), which is not on this map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Association of Androgenetic Alopecia and Severity of Coronavirus Disease 2019 (COVID-19)
Who cites it
23 citing papers in PubMed, 37 citations in OpenAlex.
- Cross-species comparative spatial transcriptomics of hair follicle-T cell interactions identifies conserved drivers of cutaneous lupus erythematosus skin disease and associated hair loss.Nature communications · 2026Article
- A Retrospective Study on COVID-19 Infections Caused by Omicron Variant with Clinical, Epidemiological, and Viral Load Evaluations in Breakthrough Infections.International journal of medical sciences · 2024Article
- Efficacy and safety of proxalutamide (GT0918) in severe or critically ill patients with COVID-19: study protocol for a prospective, open-label, single-arm, single-center exploratory trial.BMC pharmacology & toxicology · 2023Article
- The effect of COVID-19 on development of hair and nail disorders: a Turkish multicenter, controlled study.International journal of dermatology · 2023Article
- Association of androgenetic alopecia with a more severe form of COVID-19 infection.Irish journal of medical science · 2023Observational
- The Effect of Covid-19 on the Hair Diseases Observed in Health Care Providers: Analysis of 513 Participants.Dermatology practical & conceptual · 2023Article
- Relationship between hair shedding and systemic inflammation in COVID-19 pneumonia.Annals of medicine · 2022Article
- Androgens and COVID-19.Journal of cosmetic dermatology · 2022Review
- Alopecia in patients with COVID-19: A systematic review and meta-analysis.JAAD international · 2022Review
- "MATH+" Multi-Modal Hospital Treatment Protocol for COVID-19 Infection: Clinical and Scientific Rationale.Journal of clinical medicine research · 2022Review
- Roles of steroid receptors in the lung and COVID-19.Essays in biochemistry · 2021Review
- Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.Journal of cosmetic dermatology · 2021Review
- Article
- Androgenetic alopecia in women and men is not related to COVID-19 infection severity: a prospective cohort study of hospitalized COVID-19 patients.Journal of the European Academy of Dermatology and Venereology : JEADV · 2021Article
- Androgenetic alopecia and COVID-19: A review of the hypothetical role of androgens.Dermatologic therapy · 2021Review
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology.Endocrine · 2021Article
- Cardiovascular Toxicities of Androgen Deprivation Therapy.Current treatment options in oncology · 2021Review
- Reply to letter to the editor: "A response to 'Male balding is a major risk factor for severe COVID-19'".Journal of the American Academy of Dermatology · 2021Article
- Reply to: "Comment on 'Androgenetic alopecia present in the majority of patients hospitalized with COVID-19'".Journal of the American Academy of Dermatology · 2021Article
- Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial.Frontiers in medicine · 2021Article
Corrections and comments
- Commented on by
- Commented on by
- Comment on
- Erratum issuedCorrection.2021
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.